Prognostic Significance of Surface Markers Expressed in Multiple Myeloma: CD56 and Other Antigens

References

• Bataille, R., Boccadoro, M., Klein, B., Dune, B. and Pileri, A. (1992) "C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system", Blood, 80,733–737.
   Google Scholar
• Greipp, P.R., Lust, J.A., O'Fallon, M., Katzmann, J.A., Witzig, T.E. and Kyle, R.A. (1993) "Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma", Blood, 81, 3382— 3387.
   Google Scholar
• Shaughnessy, J., Tian, E., Sawyer, J., McCoy, J., Tricot, G., Jacobson, J., et al. (2003) "Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II", British Journal of Haematology, 120, 44— 52.
   PubMed Web of Science ®Google Scholar
• Dune, B.G. and Grogan, T.M. (1985) "CALLA-positive myeloma: an aggressive subtype with poor survival", Blood, 66, 229–232.
   Google Scholar
• San Miguel, J.F., Gonzalez, M., Gascon, A., Moro, M.J., Hernandez, J.M., Ortega, F., et al. (1991) "Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease", British Journal of Haematology, 77, 185— 190.
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles, G.J. and San Miguel, J.F. (1994) "Cell surface markers in multiple myeloma", Mayo Clinic Proceedings, 69, 684 — 690.
   PubMed Web of Science ®Google Scholar
• Rawstron, AC., Owen, R.G., Davies, FE., Johnson, R.J., Jones, R.A., Richards, S.J., et al. (1997) "Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage", British Journal of Haematology, 97, 46— 55.
   PubMed Web of Science ®Google Scholar
• Trowbridge, I.S. and Thomas, M.L. (1994) "CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development", Annual Review of Immunology, 12, 85— 116.
   Google Scholar
• Kishihara, K., Penninger, J., Wallace, V.A., Kundig, TM., Kawai, K., Wakeham, A., et al. (1993) "Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice", Cell, 74, 143–156.
   Google Scholar
• Thomas, M.L. (1995) "Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases", Seminars in Immunol-ogy, 7, 279–288.
   Google Scholar
• Cyster, J.G., Healy, J.I., Kishihara, K., Mak, T.W., Thomas, M.L. and Goodnow, C.C. (1996) "Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45", Nature, 381, 325–328.
   PubMed Web of Science ®Google Scholar
• Streuli, M., Hall, L.R., Saga, Y., Schlossman, S.F. and Saito, H. (1987) "Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens", Journal of Experimental Medicine, 166, 1548–1566.
   Google Scholar
• Jensen, G.S., Mant, M.J., Belch, A.J., Berenson, J.R., Ruether, B.A. and Pilarski, L.M. (1991) "Selective expression of CD45 isoforms defines CALLA + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells", Blood, 78, 711–719.
   PubMed Web of Science ®Google Scholar
• Jensen, G.S., Poppema, S., Mant, M.J. and Pilarski, L.M. (1989) "Transition in CD45 isoform expression during differentiation of normal and abnormal B cells", International Immunology, 1, 229 — 235.
   Google Scholar
• Menke, D.M., Horny, H.P., Griesser, H., Atkinson, E.J., Kaiser-ling, E. and Kyle, R.A. (1998) "Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45R0 (UCHL-1)", Journal of Clinical Pathology, 51, 432–437.
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck, C., Barille, S., Puthier, D., Rapp, M.J., Harousseau, J.L., Bataille, R., et al. (1995) "Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization", Cancer Research, 55, 3647 — 3653.
   Google Scholar
• Linsley, P.S. and Ledbetter, J.A. (1993) "The role of the CD28 receptor during T cell responses to antigen", Annual Review of Immunology, 11, 191 — 212.
   Google Scholar
• Rudd, CE., Janssen, O., Cai, Y.C., Da Silva, A.J., Raab, M. and Prasad, K.V. (1994) "Two-step TCR CD3-CD4, and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases", Immunology Today, 15, 225–234.
   Web of Science ®Google Scholar
• June, C.H., Bluestone, J.A., Nadler, L.M. and Thompson, C.B. (1994) "The B7 and CD28 receptor families", Immunology Today, 15, 321 — 337.
   Google Scholar
• Guinan, E.C., Gribben, J.G., Boussiotis, V.A., Freeman, G.J. and Nadler, L.M. (1994) "Pivotal role of the B7 : CD28 pathway in transplantation tolerance and tumor immunity", Blood, 84, 3261 — 3282.
   Google Scholar
• Kozbor, D., Moretta, A., Messner, RA., Moretta, L. and Croce, C.M. (1987) "Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells", Journal of Immunology, 138, 4128–4132.
   PubMed Web of Science ®Google Scholar
• Robillard, N., Jego, G., Pellat-Deceunynck, C., Pineau, D., Puthier, D., Mellerin, M.P., et al. (1998) "CD28, a marker associated with tumoral expansion in multiple myeloma", Clinical Cancer Research, 4, 1521 — 1526.
   Google Scholar
• Kyle, R.A. (1994) "Why better prognosis factors for myeloma are needed", Blood, 87, 1713 — 1716.
   Google Scholar
• Ahsmann, E.J., Benschop, R.J., De Gruyl, T.D., Faber, J.A., Lokhorst, H.M. and Bloem, A.C. (1993) "A novel flow cytometric assay for the quantification of adhesion of subsets within a heterogeneous cell population; analysis of lymphocyte function-associated antigen-1 (LFA-1)-mediated binding of bone marrow-derived primary tumour cells of patients with multiple myeloma", Clinical and Experimental Immunology, 93, 456–463.
   PubMed Web of Science ®Google Scholar
• Kawano, MM., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., et al. (1993) "Identification of immature and mature myeloma cells in the bone marrow of human myelomas", Blood, 82, 564— 570.
   Google Scholar
• Kawano, M.M., Mahmoud, M.S., Huang, N., Lisukov, IA., Mihara, K., Tsujimoto, T., et al. (1995) "High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma", British Journal of Haematology, 91, 860–864.
   PubMed Web of Science ®Google Scholar
• Rawstron, A.C., Barrans, S.L., Blythe, D., English, A., Richards, Si., Fenton, J.A., et al. (2001) "In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression", British Journal of Haematology, 113, 794— 802.
   Google Scholar
• Walsh, F.S. and Doherty, P. (1997) "Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance", Annual Review of Cell and Developmental Biology, 13, 425–456.
   PubMed Web of Science ®Google Scholar
• Van Camp, B., Durie, B.G., Spier, C., De Wade, M., Van Rid, I., Vela, E., et al. (1990) "Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)", Blood, 76, 377 — 382.
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck, C., Barille, S., Jego, G., Puthier, D., Robillard, N., Pineau, D., et al. (1998) "The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma", Leukemia, 12, 1977 — 1982.
   Web of Science ®Google Scholar
• Rawstron, AC., Barrans, S., Blythe, D., Davies, F., English, A., Pratt, G., et al. (1999) "Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expres-sion", British Journal of Haematology, 104, 138— 143.
   Google Scholar
• Mathew, P., Ahmann, G.J., Witzig, T.E., Roche, P.C., Kyle, R.A. and Greipp, P.R. (1995) "Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?", British Journal of Haematology, 90, 459 —461.
   PubMed Web of Science ®Google Scholar
• Sahara, N., Takeshita, A., Shigeno, K., Fujisawa, S., Takeshita, K., Naito, K., et al. (2002) "Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma", British Journal of Haematology, 117, 882–885.
   PubMed Web of Science ®Google Scholar
• Harada, H., Kawano, MM., Huang, N., Harada, Y., Iwato, K., Tanabe, O., et al. (1993) "Phenotypic difference of normal plasma cells from mature myeloma cells", Blood, 81, 2658–2663.
   Google Scholar
• Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., et al. (1988) "Autocrine generation and requirement of BSF-2/ IL-6 for human multiple myelomas", Nature, 32, 83–85.
   PubMed Web of Science ®Google Scholar
• Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., et al. (1989) "Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6", Blood, 73, 517 — 526.
   Google Scholar
• Kishimoto, T., Akira, S., Narazaki, M. and Taga, T. (1995) "Interleukin-6 family of cytokines and gp130", Blood, 86, 1243 — 1254.
   Google Scholar
• Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F. and Graeve, L. (1998) "Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway", Biochemical Journal, 334, 297 —314.
   Google Scholar
• Rawstron, AC., Fenton, J.A., Ashcroft, J., English, A., Jones, R.A., Richards, Si., et al. (2000) "The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells", Blood, 96, 3880— 3886.
   Google Scholar
• BariIle, S., Thabard, W., Robillard, N., Moreau, P., Pineau, D., Harousseau, J.L., et al. (1999) "CD130 rather than CD126 expression is associated with disease activity in multiple myeloma", British Journal of Haematology, 106, 532–535.
   Web of Science ®Google Scholar
• Kim, I., Uchiyama, H., Chauhan, D. and Anderson, K.C. (1994) "Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines", British Journal of Haematology, 87, 483–493.
   Google Scholar
• Huang, N., Kawano, M.M., Mahmoud, M.S., Mihara, K., Tsujimoto, T., Niwa, O., et al. (1995) "Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells", Blood, 85, 3704–3712.
   PubMed Web of Science ®Google Scholar
• Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T.A., et al. (1996) "Multiple myeloma cell adhesion-induced interleukin — 6 expression in bone marrow stromal cells involves activation of NF-kappa B", Blood, 87, 1104 — 1112.
   Google Scholar